← FDA Drug Approvals (Drugs@FDA)

YAELA

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2014-11-19

Drug application

FDA Application #

ANDA202015

Application type

Abbreviated New Drug Application (Generic)

Brand name

YAELA

Generic name

Drospirenone

Active ingredients

DROSPIRENONE; ETHINYL ESTRADIOL

Dosage form

TABLET

Route

ORAL-28

Marketing status

Prescription

Sponsor

NOVAST LABS

First approval

2014-11-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown